Outcome of patients on heart transplant list treated with a continuous-flow left ventricular assist device: Insights from the TRans-Atlantic registry on VAd and TrAnsplant (TRAViATA)

•Waitlisted patients in the US on CF-LVAD have higher risk comorbid conditions.•Overall outcome of waitlisted patients in the US on CF-LVAD is similar.•There are geographic variations with regards to donor characteristics and duration of CF-LVAD support prior to transplant.•Older age, use of temporary MCS, implantation of HVAD, higher BMI and creatinine are associated with increased mortality.